Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Parkinson's Nilotinib Trial Enrolling Participants

    Parkinson's Nilotinib Trial Enrolling Participants

    A Phase II clinical trial to evaluate the safety and tolerability of nilotinib in PD is under way at sites across the US.
    Learn more
  • Genetic Mutation Links Parkinson's and Crohn's Disease

    Genetic Mutation Links Parkinson's and Crohn's Disease

    This connection, published by researchers from Mount Sinai in New York City, may help better understand and treat these diseases.
    Learn more
  • Results Are in: Scientific Experts Advance Ways to Detect and Predict PD

    Results Are in: Scientific Experts Advance Ways to Detect and Predict PD

    Research project designed to look for PD biomarkers announces winners.
    Learn more
  • Rigorous Research Creates Scientific Tools to Advance Parkinson's Therapies

    Rigorous Research Creates Scientific Tools to Advance Parkinson's Therapies

    Michael J. Fox Foundation-funded researchers have created exquisitely sensitive antibodies that may help test therapies against a top Parkinson's drug target.
    Learn more
  • Brewing a Potential Marker for Parkinson's

    Brewing a Potential Marker for Parkinson's

    A recent study shows that the way people with Parkinson's process caffeine could help identify disease earlier.
    Learn more
  • MJFF Study Demonstrates Feasibility of Wearable Devices in PD Research

    MJFF Study Demonstrates Feasibility of Wearable Devices in PD Research

    Parkinson@Home lays the foundation for other studies to incorporate digital technology.
    Learn more
  • LRRK2 Drug Trial Shares Promising Results, Company to Begin Second Study

    LRRK2 Drug Trial Shares Promising Results, Company to Begin Second Study

    Denali Therapeutics announced its first-in-human LRRK2 inhibitor is safe and lowers LRRK2 protein activity in humans' body cells, meaningful milestones for this potentially disease-modifying…
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year